|
|
Office Locations:
|
44 Brattle Street 4th Floor
Cambridge, MA 02138
Phone: 617-963-8990
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Miraki Innovation is a technology investment and development firm that identifies medical breakthroughs that have the potential for global impact and builds those ideas into companies that have substantial investor returns. Miraki Innovation is based in Cambridge, Massachusetts, the U.S. epicenter for medtech research and investment. The firm announced (April 2019) the $175 million Medical Technology Breakthrough Fund. The firm has collaborative relationships with some of the top academic institutions and research organizations and agencies in the world and work proactively with them to turn medical breakthroughs into life-changing companies. The Miraki Method is a unique and efficient approach to investing that has led to the successful exits of multiple companies and created approximately $6.33 billion in capital appreciation.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
